These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Trends and challenges in immuno-oncology trials. Kiernan B Drugs Today (Barc); 2016 Jul; 52(7):387-93. PubMed ID: 27540597 [TBL] [Abstract][Full Text] [Related]
3. "Tumor immunology meets oncology" (TIMO) XI, May 22-23, 2015, Halle/Saale, Germany. Quandt D; Seliger B Cancer Immunol Immunother; 2016 May; 65(5):625-30. PubMed ID: 27060001 [No Abstract] [Full Text] [Related]
4. Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma? Cui X; Wang Q; Kang C Front Immunol; 2021; 12():788733. PubMed ID: 34777399 [No Abstract] [Full Text] [Related]
6. "Tumor Immunology Meets Oncology (TIMO) IX", May 2-4, 2013, Halle/Saale, Germany. Seliger B Cancer Immunol Immunother; 2014 Mar; 63(3):305-11. PubMed ID: 24509955 [No Abstract] [Full Text] [Related]
7. Immunological Approaches to Tumor Therapy. Proceedings from the III International Meeting on Idiotypic Network and Tumor Therapy by Gene Therapy, Drug Targeting, Vaccination, and Photodynamic Therapy. Bonn, Germany, February 29-March 2, 1996. Hybridoma; 1997 Feb; 16(1):1-137. PubMed ID: 9273346 [No Abstract] [Full Text] [Related]
8. Immuno-Oncology in China. Lu S; Chabner BA Oncologist; 2019 Feb; 24(Suppl 1):S1-S2. PubMed ID: 30819825 [TBL] [Abstract][Full Text] [Related]
9. [The future of oncology has begun]. Stiefelhagen P MMW Fortschr Med; 2016 Jun; 158(12):16. PubMed ID: 27323979 [No Abstract] [Full Text] [Related]
10. Nanotherapeutics for Immuno-Oncology: A Crossroad for New Paradigms. Song W; Das M; Chen X Trends Cancer; 2020 Apr; 6(4):288-298. PubMed ID: 32209444 [TBL] [Abstract][Full Text] [Related]
11. "Tumor immunology meets oncology" (TIMO) X, May 23-24, 2014, Halle/Saale, Germany. Quandt D; Seliger B Cancer Immunol Immunother; 2015 Apr; 64(4):519-26. PubMed ID: 25680628 [TBL] [Abstract][Full Text] [Related]
12. Immuno-oncology drug development forges on despite COVID-19. Upadhaya S; Hubbard-Lucey VM; Yu JX Nat Rev Drug Discov; 2020 Nov; 19(11):751-752. PubMed ID: 32948858 [No Abstract] [Full Text] [Related]
13. Trends in the global immuno-oncology landscape. Tang J; Pearce L; O'Donnell-Tormey J; Hubbard-Lucey VM Nat Rev Drug Discov; 2018 Nov; 17(11):783-784. PubMed ID: 30337722 [No Abstract] [Full Text] [Related]
14. From New directions in immuno-oncology. Romero D Nat Rev Clin Oncol; 2019 Nov; 16(11):660. PubMed ID: 31541198 [No Abstract] [Full Text] [Related]
18. Cancer immunotherapy: breaking the barriers to harvest the crop. Pardoll D; Allison J Nat Med; 2004 Sep; 10(9):887-92. PubMed ID: 15340404 [TBL] [Abstract][Full Text] [Related]
19. [New treatments in immuno-oncology: a revolution and a formidable scientific and clinical challenge]. Champiat S; Soria JC Med Sci (Paris); 2017; 33(6-7):563-564. PubMed ID: 28990546 [No Abstract] [Full Text] [Related]
20. [Advances in medical oncology]. Shi YK Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]